drug
surovatamig
Phase 2updated 3mo agoby $AZN ASTRAZENECA PLC
Phase 2community read0 votes
indications
indications
DLBCL
all catalysts(0)
nothing on the calendar yet
Trials studying surovatamig
- phase3A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- phase2Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- phase3Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- phase2A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
- phase2A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- phase1Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that